GATA3 Inhibits Breast Cancer Metastasis through the Reversal of Epithelial-Mesenchymal Transition*
暂无分享,去创建一个
Wei Yan | Richard B. Arenas | R. Shao | Wei Yan | Rong Shao | Qing Jackie Cao | Brooke Bentley | R. Arenas | B. Bentley | Q. Cao | Brooke Bentley
[1] P. Brown,et al. Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes. , 1999, Nucleic acids research.
[2] Rajesh V. Thakker,et al. GATA3 haplo-insufficiency causes human HDR syndrome , 2000, Nature.
[3] J. Herman,et al. Methylation Patterns of the E-cadherin 5′ CpG Island Are Unstable and Reflect the Dynamic, Heterogeneous Loss of E-cadherin Expression during Metastatic Progression* , 2000, The Journal of Biological Chemistry.
[4] P. Stern,et al. Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. , 2007, Cancer research.
[5] D. Chopin,et al. Epithelial Cell Plasticity in Development and Tumor Progression , 2004, Cancer and Metastasis Reviews.
[6] Zena Werb,et al. GATA-3 Maintains the Differentiation of the Luminal Cell Fate in the Mammary Gland , 2006, Cell.
[7] W. Ouyang,et al. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. , 1998, Immunity.
[8] P. Savagner,et al. Leaving the neighborhood: molecular mechanisms involved during epithelial‐mesenchymal transition , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.
[9] S. Orkin,et al. DNA-binding specificity of GATA family transcription factors , 1993, Molecular and cellular biology.
[10] J. McGhee,et al. The GATA family (vertebrates and invertebrates). , 2002, Current opinion in genetics & development.
[11] R. Weigel,et al. GATA-3 expression as a predictor of hormone response in breast cancer. , 2005, Journal of the American College of Surgeons.
[12] K. Pantel,et al. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases. , 1999, Cancer research.
[13] J. Leiden,et al. Transcription factor GATA-3 is required for development of the T-cell lineage , 1996, Nature.
[14] W. Birchmeier,et al. Epithelial-mesenchymal transitions in cancer progression. , 1996, Acta anatomica.
[15] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[16] B. Boyer,et al. Model systems of epithelium-mesenchyme transitions. , 1996, Acta anatomica.
[17] Samuel Granjeaud,et al. Expression scanning of an array of growth control genes in human tumor cell lines , 1999, Oncogene.
[18] M. J. van de Vijver,et al. Simultaneous loss of E‐cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ , 1997, The Journal of pathology.
[19] M. Stack,et al. Proteinase Suppression by E-cadherin-mediated Cell-Cell Attachment in Premalignant Oral Keratinocytes* , 2002, The Journal of Biological Chemistry.
[20] J. Downward,et al. Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis , 2002, The Journal of Cell Biology.
[21] A Radbruch,et al. Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. , 2000, Immunity.
[22] R. Shao,et al. Transduction of a Mesenchyme-specific Gene Periostin into 293T Cells Induces Cell Invasive Activity through Epithelial-Mesenchymal Transformation* , 2006, Journal of Biological Chemistry.
[23] Marie-Liesse Asselin-Labat,et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation , 2007, Nature Cell Biology.
[24] J. D. Engel,et al. DNA-binding specificities of the GATA transcription factor family , 1993, Molecular and cellular biology.
[25] Debashis Ghosh,et al. Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. , 2005, Cancer research.
[26] Wenjun Guo,et al. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.
[27] M. Ladanyi,et al. E-cadherin mutation and Snail overexpression as alternative mechanisms of E-cadherin inactivation in synovial sarcoma , 2004, Oncogene.
[28] Francisco Portillo,et al. The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.
[29] Allan Balmain,et al. TGFβ1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice , 1996, Cell.
[30] P. Romeo,et al. Human GATA-3 trans-activation, DNA-binding, and nuclear localization activities are organized into distinct structural domains , 1994, Molecular and cellular biology.
[31] A. G. Herreros,et al. The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells , 2000, Nature Cell Biology.
[32] R. Weigel,et al. GATA‐3 is expressed in association with estrogen receptor in breast cancer , 1999, International journal of cancer.
[33] C. Perou,et al. Common Genetic Variation in GATA-Binding Protein 3 and Differential Susceptibility to Breast Cancer by Estrogen Receptor α Tumor Status , 2007, Cancer Epidemiology Biomarkers & Prevention.
[34] J. Alberola-Ila,et al. GATA-3 expression is controlled by TCR signals and regulates CD4/CD8 differentiation. , 2003, Immunity.
[35] B. Harding,et al. Characterization of GATA3 Mutations in the Hypoparathyroidism, Deafness, and Renal Dysplasia (HDR) Syndrome* , 2002, Journal of Biological Chemistry.
[36] J. Foidart,et al. E-Cadherin mediates MMP down-regulation in highly invasive bronchial tumor cells. , 2003, The American journal of pathology.
[37] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[38] T. Nielsen,et al. GATA-3 Expression in Breast Cancer Has a Strong Association with Estrogen Receptor but Lacks Independent Prognostic Value , 2008, Cancer Epidemiology Biomarkers & Prevention.
[39] Jérôme Eeckhoute,et al. Positive Cross-Regulatory Loop Ties GATA-3 to Estrogen Receptor α Expression in Breast Cancer , 2007 .
[40] Z. Werb,et al. GATA-3 and the regulation of the mammary luminal cell fate. , 2008, Current opinion in cell biology.
[41] Z. Werb,et al. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. , 2008, Cancer cell.
[42] Richard A Flavell,et al. The Transcription Factor GATA-3 Is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T Cells , 1997, Cell.
[43] D. Tarin,et al. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? , 2005, Cancer research.
[44] J. Herman,et al. Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer. , 2000, Cancer research.
[45] R. Weinberg,et al. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.
[46] K. Murphy,et al. Structure and Specificity of GATA Proteins in Th2 Development , 2001, Molecular and Cellular Biology.
[47] R. Strausberg,et al. Mutation of GATA3 in human breast tumors , 2004, Oncogene.